Literature DB >> 11154915

Evasion of host cell defense mechanisms by pathogenic bacteria.

J Pieters1.   

Abstract

From an immunological viewpoint, invasion of pathogenic bacteria into a susceptible host poses a potential life-threatening situation and thus has to be met with all weapons that are available. A crucial component of host defense mechanisms is the macrophage. The scavenger activity of this cell ensures the uptake and destruction of bacteria in phagolysosomes, on the one hand, and activation of the adaptive component of the immune system through presentation of bacterial antigens, on the other hand. From the bacterial perspective, entry into a phagolysosome is usually fatal and many pathogens have developed strategies that circumvent the destructive environment of this organelle. Such evasion strategies often exploit normal host cell function. Understanding these survival strategies will deepen our insight of the pathogenesis of infection as well as host cell biology.

Entities:  

Mesh:

Year:  2001        PMID: 11154915     DOI: 10.1016/s0952-7915(00)00179-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  21 in total

1.  Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.

Authors:  Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Keisuke Sano; Toshiaki Shimizu
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A.

Authors:  Sunil K Sukumaran; Hiroyuki Shimada; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  Role of protein kinase G in growth and glutamine metabolism of Mycobacterium bovis BCG.

Authors:  Liem Nguyen; Anne Walburger; Edith Houben; Anil Koul; Stefan Muller; Monika Morbitzer; Bert Klebl; Giorgio Ferrari; Jean Pieters
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

Review 4.  Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence.

Authors:  Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

5.  Human macrophage activation programs induced by bacterial pathogens.

Authors:  Gerard J Nau; Joan F L Richmond; Ann Schlesinger; Ezra G Jennings; Eric S Lander; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 6.  Mycobacterium tuberculosis, autoimmunity, and vitamin D.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

7.  IL-6 induced by Staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice.

Authors:  E B Ahmed; T Wang; M Daniels; M-L Alegre; A S Chong
Journal:  Am J Transplant       Date:  2011-03-30       Impact factor: 8.086

8.  Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway.

Authors:  Nobuo Okahashi; Hiroaki Inaba; Ichiro Nakagawa; Taihei Yamamura; Masae Kuboniwa; Koji Nakayama; Shigeyuki Hamada; Atsuo Amano
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  RNA interference in J774 macrophages reveals a role for coronin 1 in mycobacterial trafficking but not in actin-dependent processes.

Authors:  Rajesh Jayachandran; John Gatfield; Jan Massner; Imke Albrecht; Bettina Zanolari; Jean Pieters
Journal:  Mol Biol Cell       Date:  2007-12-27       Impact factor: 4.138

Review 10.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.